CHARLOTTE, NC / ACCESS Newswire / November 2, 2026 / cbdMD, Inc. (NYSE American:YCBD) ("cbdMD" or the "Company"), a leading wellness company, today announced that it ...

NEW YORK, Nov. 2, 2026 /PRNewswire/ -- The UN Global Compact Network USA ( Network USA) welcomes Allyson Anderson Book, Chief Sustainability Officer at Baker Hughes, to its Board of Directors.

Desjardins analyst Alexander Leon lowered the price target on Morguard North American Residential REIT (MRG-U:CN) (OTC: MNARF) to Cdn$17.25 (from Cdn$19.50) while maintaining a Buy rating.

RBC Capital analyst Drew McReynolds lowered the price target on Cogeco Communications Inc. (CCA:CN) (OTC: CGEAF) to Cdn$63.00 (from Cdn$65.00) while maintaining a Sector Perform rating.

The vendor buyers favor before contacting a seller wins 82% of the time, and 96% of buyers follow vendors between purchase cycles  LAS VEGAS--(BUSINESS WIRE)-- 6sense®, the Agentic GTM Partner, ...

Acquisition adds 115 billboard faces, including eleven digital displays, strengthening one of the Carolinas' largest regional out-of-home advertising networks MYRTLE BEACH, S.C.--(BUSINESS WIRE)-- ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced that an abstract on its investigational drug ATNM-400 has been accepted for poster presentation at the 2026 San Antonio Breast Cancer ...

First Resource Bank (OTC: FRSB) declared a quarterly dividend of $0.02 per share, or $0.08 annualized.The dividend will be payable on December 2, 2026, to stockholders of record on November 18, 2026, ...

Strategic partnership unites AI-native cybersecurity and observability to accelerate investigations, reduce data costs, and free customers from legacy platform lock-in AUSTIN, Texas, & BOSTON & ...

Baird Medical Investment Holdings Limited (NASDAQ: BDMD) announced that its China subsidiary, Nanjing Changcheng Medical Equipment Company Limited, has entered into an exclusive distribution agreement ...

Axcelis Technologies (NASDAQ: ACLS) and Veeco Instruments (NASDAQ: VECO) said their previously announced all-stock merger is now expected to ...

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) presented a subgroup analysis from its Phase 3 RAPID clinical trial at the American Heart Association Scientific Sessions 2026, showing that CARDAMYST ...